Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 206,141,806 papers from all fields of science
Search
Sign In
Create Free Account
Slo-Niacin
Known as:
slo niacin
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Niacin
Niacin 500 MG Extended Release Oral Tablet [Slo-Niacin]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
An adaptive optics imaging system designed for clinical use.
Jie Zhang
,
Qiang Yang
,
Kenichi Saito
,
Koji Nozato
,
David Williams
,
E. Rossi
Biomedical optics express
2015
Corpus ID: 34942952
Here we demonstrate a new imaging system that addresses several major problems limiting the clinical utility of conventional…
Expand
2014
2014
Microstructure of subretinal drusenoid deposits revealed by adaptive optics imaging.
A. Meadway
,
Xiaolin Wang
,
C. Curcio
,
Yuhua Zhang
Biomedical optics express
2014
Corpus ID: 1324294
Subretinal drusenoid deposits (SDD), a recently recognized lesion associated with progression of age-related macular degeneration…
Expand
Highly Cited
2013
Highly Cited
2013
High-resolution imaging of retinal nerve fiber bundles in glaucoma using adaptive optics scanning laser ophthalmoscopy.
K. Takayama
,
S. Ooto
,
+8 authors
N. Yoshimura
American journal of ophthalmology
2013
Corpus ID: 34757402
2013
2013
Reduction of Streptolysin O (SLO) Pore-Forming Activity Enhances Inflammasome Activation
Peter A Keyel
,
Robyn Roth
,
W. Yokoyama
,
J. Heuser
,
R. Salter
Toxins
2013
Corpus ID: 11868955
Pore-forming toxins are utilized by bacterial and mammalian cells to exert pathogenic effects and induce cell lysis. In addition…
Expand
2013
2013
Disruption of the human cone photoreceptor mosaic from a defect in NR2E3 transcription factor function in young adults
S. P. Park
,
I. Hong
,
+5 authors
Stanley Chang
Graefe's Archive for Clinical and Experimental…
2013
Corpus ID: 11322367
BackgroundEnhanced S-cone syndrome is an orphan disease caused by mutations in the NR2E3 gene which result in an increased number…
Expand
Review
2012
Review
2012
Worms take to the slo lane: a perspective on the mode of action of emodepside
L. Holden-Dye
,
Anna Crisford
,
C. Welz
,
G. von Samson-Himmelstjerna
,
R. Walker
,
V. O’Connor
Invertebrate Neuroscience
2012
Corpus ID: 16094344
The cyclo-octapdepsipeptide anthelmintic emodepside exerts a profound paralysis on parasitic and free-living nematodes. The…
Expand
2010
2010
An adaptive-optics scanning laser ophthalmoscope for imaging murine retinal microstructure
C. Alt
,
D. Biss
,
N. Tajouri
,
T. Jakobs
,
Charles P. Lin
BiOS
2010
Corpus ID: 97982204
In vivo retinal imaging is an outstanding tool to observe biological processes unfold in real-time. The ability to image…
Expand
Highly Cited
2009
Highly Cited
2009
In-vivo imaging of retinal nerve fiber layer vasculature: imaging - histology comparison
Drew Scoles
,
Daniel C. Gray
,
+8 authors
W. Merigan
BMC ophthalmology
2009
Corpus ID: 628639
BackgroundAlthough it has been suggested that alterations of nerve fiber layer vasculature may be involved in the etiology of eye…
Expand
2005
2005
Syntaxin-1A binds to and modulates the Slo calcium-activated potassium channel via an interaction that excludes syntaxin binding to calcium channels.
S. M. Cibulsky
,
H. Fei
,
I. Levitan
Journal of neurophysiology
2005
Corpus ID: 626584
From its position in presynaptic nerve terminals, the large conductance Ca(2+)-activated K+ channel, Slo, regulates…
Expand
1998
1998
Fluorescent infrared scanning-laser ophthalmoscope for three-dimensional visualization: automatic random-eye-motion correction and deconvolution.
N. O'Connor
,
D. Bartsch
,
W. J. Freeman
,
A. Mueller
,
T. Holmes
Applied optics
1998
Corpus ID: 38607169
Scanning-laser ophthalmoscope (SLO) technology has provided, among other possibilities, the potential for three-dimensional (3-D…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE